SEC filing: Statement of changes in beneficial ownership of securities Share on Facebook Share on Facebook Share on LinkedIn Share on LinkedIn Share on X Share on X Share on Pinterest Share on Pinterest Share via email Share via email
investor nutraceuticals medicine press clippings LA Weekly: The Enzyme Frontier - eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and Pharma Article excerpt Read more
investor press clippings Slack Capital report: EXOZ is a once-in-a-lifetime opportunity Report excerpteXoZymes’ recent Q3 investor call was, in my view, a genuine inflection point for the... Read more
heltzen investor nutraceuticals medicine press clippings video 'The Upside' interview: Michael Heltzen & Lou Basenese Read more